Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy
Part of paid clinical trials in Berkeley, California.
- Sponsor
- Genzyme, a Sanofi Company
- Study ID
- NCT00364351
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Vandetanib — DRUGonce daily oral tablet
- Erlotinib — DRUGoral dose
Study Details
To determine if ZD6474 a new investigational drug, is effective in treating Non Small Lung Cancer and if so, how it compares with another type of anti cancer therapy chemotherapy, Erlotinib
Key Dates
- First listed
- Aug 15, 2006
- Start date
- Aug 31, 2006
- Status verified
- Jan 2018
- Primary completion
- Sep 30, 2008
- Completion
- Nov 30, 2016
Study Design
- Enrollment
- 1,574 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: 1Erlotinib
- Experimental: 2Vandetanib
Primary Outcome Measure
Progression-Free Survival (PFS) [ Time Frame: progressionRECIST tumour assessments carried out every 4 weeks up to week 16 then every 8 weeks thereafter from randomisation until the date of first documented objective disease progression or date of death from any cause, whichever came first, assessed. ]
Locations (29)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Site | Berkeley | California | - | - |
| Research Site | Los Angeles | California | - | - |
| Research Site | Santa Rosa | California | - | - |
| Research Site | Boynton Beach | Florida | - | - |
| Research Site | Fort Myers | Florida | - | - |
| Research Site | Jacksonville | Florida | - | - |
| Research Site | Port Saint Lucie | Florida | - | - |
| Research Site | Wichita | Kansas | - | - |
| Research Site | Lexington | Kentucky | - | - |
| Research Site | Louisville | Kentucky | - | - |
| Research Site | Metairie | Louisiana | - | - |
| Research Site | Baltimore | Maryland | - | - |
| Research Site | Columbia | Missouri | - | - |
| Research Site | St Louis | Missouri | - | - |
| Research Site | Latham | New York | - | - |
| Research Site | Hickory | North Carolina | - | - |
| Research Site | Canton | Ohio | - | - |
| Research Site | Cincinnati | Ohio | - | - |
| Research Site | Greenville | South Carolina | - | - |
| Research Site | Chattanooga | Tennessee | - | - |
| Research Site | Nashville | Tennessee | - | - |
| Research Site | Amarillo | Texas | - | - |
| Research Site | Garland | Texas | - | - |
| Research Site | Webster | Texas | - | - |
| Research Site | Fairfax | Virginia | - | - |
| Research Site | Norfolk | Virginia | - | - |
| Research Site | Richmond | Virginia | - | - |
| Research Site | Burien | Washington | - | - |
| Research Site | Yakima | Washington | - | - |
Find similar trials in Berkeley, CA
By condition
By specialty
Related Studies
- The Effect of Beta-glucan in Non-Small Cell Lung CancerRecruiting · University of Louisville · Louisville, Kentucky
- Dabrafenib and/or Trametinib Rollover StudyPHASE4 · Recruiting · Novartis Pharmaceuticals · Scottsdale, Arizona
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Tumor Cell and DNA Detection in the Blood, Urine, and Bone MarrowRecruiting · University of Missouri-Columbia · Columbia, Missouri